What we're seeing big pharma start to do now is better molecular phenotyping of patients to identify responders and non-responders." Learning from Ground Squirrels, Elephant Seals This hunt for new solutions has scientists looking in unexpected places researchers at Fauna Bio are studying hibernating animals that maintain muscle mass despite months without eating
Seino Y, Terauchi Y, Osonoi T, Yabe D, Abe N, Nishida T, Zacho J, Kaneko S
Mochi for transparent pricing
They are deliberate design choices that determine a compound bioavailability, stability, shelf life, and practical utility
CrossRef Prognostic impact of body composition in hepatocellular carcinoma patients undergoing interventional and systemic therapy Yun Feng, Bingran Yu, Anxiao Liu, Chongpeng Cai, Changming Zhou, Tong Tong, Lu Wang, Qi Pan Frontiers in Nutrition .2025;[Epub] CrossRef The Unequal Burden of Metabolic DysfunctionAssociated Steatotic Liver Disease in 204 Countries and Territories From 1990 to 2021 Junqiao Feng, Yudan Fan Liver International .2025;[Epub] CrossRef Chronic Hepatitis B and MASLD: Growing Awareness and Unmet Clinical Needs Nicola Pugliese, Davide Polverini, Stefano Ciardullo Liver International .2025;[Epub] CrossRef MultiCenter, MultiVendor Validation of Simultaneous MRIBased Proton Density Fat Fraction and R2* Mapping Using a Combined Proton Density Fat FractionR2* Phantom Jitka Starekova, David Rutkowski, Won C